Status
Conditions
Treatments
About
Main objective is to improve colorectal cancer (CRC) screening programme in the Czech Republic and decrease the disease incidence and mortality. The secondary aim is to verify the effectiveness of incorporation of the new minimally invasive device in the prevention programme.
Full description
Multicentre, multidisciplinary (3 gastroenterology units; biostatistics department; cooperation with general practitioners), prospective study is focused on examination of individuals with average colorectal cancer (CRC) risk (asymptomatic, age 50-75 years).
In years 2017 - 2019, there will be 230 persons with positive semi-quantitative immunochemical fecal occult blood tests (FIT; QuikRead, Orion Diagnostica Oy, Finland) with cut-off level 75 ng/ml involved. Every person will be examined by second generation colon capsule endoscopy (CCE2) and optical colonoscopy afterwards.
Main objective is to show that the negative predictive value (NPV) of the CCE2 applied in patients with positive FIT results is sufficient to include this method in the National CRC screening as filter test with aim to reduce the necessity of subsequent optical colonoscopy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
CRC high-risk group patients
recent diagnostic, follow-up or preventive colonoscopy in ≤ 3 years (FOBT-positive colonoscopy, screening colonoscopy)
colonoscopy contraindication
severe acute inflammatory bowel disease
severe comorbidities; likely non-compliance of the patient
no informed consent signed (with the study and/or with colonoscopy)
Primary purpose
Allocation
Interventional model
Masking
230 participants in 1 patient group
Loading...
Central trial contact
Stepan Suchanek, MD., Ph.D.; Michal Voska
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal